アスタキサンチンの世界市場予測（～2022年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKETS COVERED 17
1.4 PERIODIZATION CONSIDERED FOR THE STUDY 18
1.5 CURRENCY 18
1.6 UNITS 18
1.7 STAKEHOLDERS 18

2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Key data from primary sources 21
2.1.2.2 Key industry insights 22
2.1.2.3 Breakdown of primaries 22
2.2 MACROINDICATORS 23
2.2.1 INTRODUCTION 23
2.2.2 INCREASING GERIATRIC POPULATION 23
2.2.3 CHANGING CONSUMPTION PATTERNS 24
2.2.4 PREVALENCE OF NUTRITIONAL DEFICIENCY 25
2.3 MARKET SIZE ESTIMATION 25
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 28
2.5 ASSUMPTIONS AND LIMITATIONS 29
2.5.1 ASSUMPTIONS 29
2.5.2 LIMITATIONS 29

3 EXECUTIVE SUMMARY 30
3.1 ASTAXANTHIN MARKET, BY SOURCE TYPE 32

4 PREMIUM INSIGHTS 37
4.1 ATTRACTIVE OPPORTUNITIES IN THE ASTAXANTHIN MARKET 37
4.2 ASTAXANTHIN MARKET, BY REGION 38
4.3 ASIA-PACIFIC ASTAXANTHIN MARKET, BY COUNTRY AND SOURCE 39
4.4 ASTAXANTHIN MARKET, BY APPLICATION 40
4.5 ASTAXANTHIN MARKET, BY SOURCE 41
4.6 PRODUCT LIFE CYCLE, BY REGION 42

5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 44
5.2.1 DRIVERS 45
5.2.1.1 Growing awareness toward preventive healthcare & nutraceuticals 45
5.2.1.2 Industrialization of the feed market 47
5.2.1.3 Increasing demand for cosmetic products 48
5.2.2 RESTRAINTS 49
5.2.2.1 High cost of production 49
5.2.3 OPPORTUNITIES 49
5.2.3.1 Government initiatives to support aquaculture 49
5.2.3.2 Growing demand for natural antioxidants 50
5.2.3.3 Growing demand from emerging countries 50
5.2.4 CHALLENGES 50
5.2.4.1 Adulteration and clean label requirements 50
5.2.4.2 Government regulations in different countries 51
5.3 VALUE CHAIN ANALYSIS 52
5.4 SUPPLY CHAIN ANALYSIS 53

6 ASTAXANTHIN MARKET, BY SOURCE 54
6.1 INTRODUCTION 55
6.2 NATURAL SOURCE 56
6.2.1 PLANTS 56
6.2.2 YEAST & MICROBES 57
6.2.3 MARINE 58
6.3 PETROLEUM (SYNTHETIC) 59

7 ASTAXANTHIN MARKET, BY APPLICATION 60
7.1 INTRODUCTION 61
7.2 FEED 62
7.3 SUPPLEMENTS 64
7.4 FOOD 65
7.5 COSMETICS 67

8 ASTAXANTHIN MARKET, BY FORM 68
8.1 INTRODUCTION 69
8.2 DRY FORM 70
8.3 LIQUID FORM 71
 

9 ASTAXANTHIN MARKET, BY METHOD OF PRODUCTION 72
9.1 INTRODUCTION 72
9.2 MICROALGAE CULTIVATION 73
9.3 FERMENTATION 74
9.4 EXTRACTION 75
9.5 CHEMICAL SYNTHESIS 76

10 ASTAXANTHIN MARKET, BY REGION 78
10.1 INTRODUCTION 79
10.2 NORTH AMERICA 80
10.2.1 U.S. 82
10.2.2 CANADA 83
10.2.3 MEXICO 83
10.3 EUROPE 86
10.3.1 GERMANY 88
10.3.2 FRANCE 88
10.3.3 ITALY 88
10.3.4 U.K. 88
10.3.5 SPAIN 88
10.3.6 REST OF EUROPE 88
10.4 ASIA-PACIFIC 92
10.4.1 CHINA 94
10.4.2 INDIA 95
10.4.3 AUSTRALIA & NEW ZEALAND 95
10.4.4 REST OF ASIA-PACIFIC 95
10.5 REST OF THE WORLD (ROW) 99
10.5.1 SOUTH AMERICA 99
10.5.2 MIDDLE EAST 100
10.5.3 OTHERS IN ROW 100

11 BRAND OVERVIEW 104
11.1 INTRODUCTION 104
11.2 BRANDS FOR ANIMAL APPLICATION 104
11.2.1 ASTAREAL 104
11.2.2 ECOTONE 104
11.2.3 ASTAMARINE 104
11.3 BRANDS FOR HUMAN APPLICATION 105
11.3.1 ASTASANA 105
11.3.2 ASTAREAL 105
11.3.3 BIOASTIN 105
11.3.4 ASTAZINE 105
11.3.5 ZANTHIN 105
11.3.6 ASTAPURE 106
11.3.7 ASTASUPREME 106
11.3.8 ASTAMARINE 106

12 REGULATIONS GOVERNING THE ASTAXANTHIN MARKET 107
12.1 OVERVIEW 107
12.2 NORTH AMERICA 107
12.2.1 CANADA 107
12.2.2 U.S. 108
12.3 EUROPEAN UNION (EU) 108
12.4 MAJOR PATENTS 109

13 COMPETITIVE LANDSCAPE 110
13.1 INTRODUCTION 110
13.2 VENDOR DIVE ANALYSIS 110
13.2.1 VANGUARDS 110
13.2.2 INNOVATOR 110
13.2.3 DYNAMIC 111
13.2.4 EMERGING 111
13.3 COMPETITIVE BENCHMARKING 112
13.3.1 PRODUCT OFFERING (FOR ALL 22 PLAYERS) 112
13.3.2 BUSINESS STRATEGY (FOR ALL 22 PLAYERS) 113
*Top 22 companies analyzed for this study are – BASF SE (Germany), Koninklijke DSM N.V (Netherlands), Fuji Chemical Industries Co., Ltd (Japan), Cardax, Inc. (U.S.), BGG (Beijing Ginko Group) (U.S.), Igene Biotechnology, Inc. (U.S.), JX Nippon Oil & Energy Co. (Japan), Valensa International (U.S.), Otsuka Pharmaceutical (Japan), Cyanotech Corporation (U.S.), Viva Naturals (U.S.), Algatechnologies (Israel), Piveg Inc. (Mexico), Regenurex Health Corporation (Canada), Core Products Europe Ltd (U.K.), Atacama Bio Natural Products S.A. (Chile, South America), BlueOcean NutraSciences (Canada), Divis Laboratories Ltd. (India), Spec-Chem Industry Inc (China), NutraMarks, Inc (U.S.), Supreme Biotechnologies NZ Ltd (NZ), FENCHEM BIOTEK LTD. (China)

14 COMPANY PROFILES 114
(Business Overview, Products offered & Services strategies, Key Insights, Recent Developments, MnM View)*
14.1 KONINKLIJKE DSM N.V. 114
14.2 BASF SE 118
14.3 CYANOTECH CORPORATION 121
14.4 OTSUKA PHARMACEUTICAL CO., LTD. 124
14.5 VALENSA INTERNATIONAL 128
14.6 FUJI CHEMICAL INDUSTRIES CO., LTD. 132
14.7 DIVIS LABORATORIES LTD. 135
14.8 BEIJING GINKO GROUP (BGG) 138
14.9 IGENE BIOTECHNOLOGY INC. 141
14.10 PIVEG, INC. 143
14.11 FENCHEM BIOTEK LTD. 145
14.12 ALGATECHNOLOGIES 148
14.13 CARDAX, INC. 150
14.14 SUPREME BIOTECHNOLOGIES 153
*Details on Business Overview, Products offered & Services strategies, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.

15 APPENDIX 155
15.1 DISCUSSION GUIDE 155
15.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 158
15.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 160
15.4 AVAILABLE CUSTOMIZATIONS 161
15.5 RELATED REPORTS 162
15.6 AUTHOR DETAILS 163